164 related articles for article (PubMed ID: 37955864)
1. Reduced Quality of Life in Former Androgen Users: An Evolving Public-Health Concern.
Pope HG; Kanayama G
J Clin Endocrinol Metab; 2024 Apr; 109(5):e1400-e1401. PubMed ID: 37955864
[No Abstract] [Full Text] [Related]
2. Use, Misuse and Abuse of Testosterone and Other Androgens.
Linhares BL; Miranda EP; Cintra AR; Reges R; Torres LO
Sex Med Rev; 2022 Oct; 10(4):583-595. PubMed ID: 37051948
[TBL] [Abstract][Full Text] [Related]
3. Use, Misuse and Abuse of Testosterone and Other Androgens.
Linhares BL; Miranda EP; Cintra AR; Reges R; Torres LO
Sex Med Rev; 2022 Oct; 10(4):583-595. PubMed ID: 34887237
[TBL] [Abstract][Full Text] [Related]
4. Prolonged hypogonadism in males following withdrawal from anabolic-androgenic steroids: an under-recognized problem.
Kanayama G; Hudson JI; DeLuca J; Isaacs S; Baggish A; Weiner R; Bhasin S; Pope HG
Addiction; 2015 May; 110(5):823-31. PubMed ID: 25598171
[TBL] [Abstract][Full Text] [Related]
5. Persistently Decreased Quality of Life and its Determinants in Previous Illicit Androgen Users.
Bulut Y; Brandt-Jacobsen N; Buhl L; Schou M; Frystyk J; Kistorp C; Rasmussen JJ
J Clin Endocrinol Metab; 2024 Jan; 109(2):e689-e697. PubMed ID: 37708363
[TBL] [Abstract][Full Text] [Related]
6. Effects of Anabolic Androgenic Steroids on the Reproductive System of Athletes and Recreational Users: A Systematic Review and Meta-Analysis.
Christou MA; Christou PA; Markozannes G; Tsatsoulis A; Mastorakos G; Tigas S
Sports Med; 2017 Sep; 47(9):1869-1883. PubMed ID: 28258581
[TBL] [Abstract][Full Text] [Related]
7. Survey of endocrinologists managing recovery from anabolic androgenic steroid induced hypogonadism.
Grant B; Pradeep A; Minhas S; Dhillo WS; Quinton R; Jayasena CN
Reprod Fertil; 2023 Jan; 4(1):. PubMed ID: 36757334
[TBL] [Abstract][Full Text] [Related]
8. Studies of athlete biological passport biomarkers and clinical parameters in male and female users of anabolic androgenic steroids and other doping agents.
Börjesson A; Lehtihet M; Andersson A; Dahl ML; Vicente V; Ericsson M; Ekström L
Drug Test Anal; 2020 Apr; 12(4):514-523. PubMed ID: 31925932
[TBL] [Abstract][Full Text] [Related]
9. Anabolic steroid induced hypogonadism in young men.
Coward RM; Rajanahally S; Kovac JR; Smith RP; Pastuszak AW; Lipshultz LI
J Urol; 2013 Dec; 190(6):2200-5. PubMed ID: 23764075
[TBL] [Abstract][Full Text] [Related]
10. Structural characteristics of anabolic androgenic steroids contributing to binding to the androgen receptor and to their anabolic and androgenic activities. Applied modifications in the steroidal structure.
Fragkaki AG; Angelis YS; Koupparis M; Tsantili-Kakoulidou A; Kokotos G; Georgakopoulos C
Steroids; 2009 Feb; 74(2):172-97. PubMed ID: 19028512
[TBL] [Abstract][Full Text] [Related]
11. Factors predicting normalization of reproductive hormones after cessation of anabolic-androgenic steroids in men: a single center retrospective study.
Grant B; Campbell J; Pradeep A; Burns AD; Bassett P; Abbara A; Saket P; Minhas S; Dhillo WS; McVeigh J; Bhasin S; Jayasena CN
Eur J Endocrinol; 2023 Dec; 189(6):601-610. PubMed ID: 38102386
[TBL] [Abstract][Full Text] [Related]
12. Anabolic androgenic steroid-induced hypogonadism, a reversible condition in male individuals? A systematic review.
Vilar Neto JO; da Silva CA; Bruno da Silva CA; Pinto DV; Caminha JSR; de Matos RS; Nunes Filho JCC; Alves FR; Magalhães SC; De Francesco Daher E
Andrologia; 2021 Aug; 53(7):e14062. PubMed ID: 33887077
[TBL] [Abstract][Full Text] [Related]
13. Serum Insulin-like Factor 3 Levels Are Reduced in Former Androgen Users, Suggesting Impaired Leydig Cell Capacity.
Rasmussen JJ; Albrethsen J; Frandsen MN; Jørgensen N; Juul A; Kistorp C
J Clin Endocrinol Metab; 2021 Jun; 106(7):e2664-e2672. PubMed ID: 33693710
[TBL] [Abstract][Full Text] [Related]
14. Abuse of anabolic androgenic steroids and related substances in sport and exercise.
Bahrke MS; Yesalis CE
Curr Opin Pharmacol; 2004 Dec; 4(6):614-20. PubMed ID: 15525553
[TBL] [Abstract][Full Text] [Related]
15. Effects of androgens on haemostasis.
Winkler UH
Maturitas; 1996 Jul; 24(3):147-55. PubMed ID: 8844628
[TBL] [Abstract][Full Text] [Related]
16. The influence of pharmaceutical compounds on male fertility.
Neumann F; Diallo FA; Hasan SH; Schenck B; Traore I
Andrologia; 1976; 8(3):203-35. PubMed ID: 793446
[TBL] [Abstract][Full Text] [Related]
17. Advantages and Limitations of Androgen Receptor-Based Methods for Detecting Anabolic Androgenic Steroid Abuse as Performance Enhancing Drugs.
Bailey K; Yazdi T; Masharani U; Tyrrell B; Butch A; Schaufele F
PLoS One; 2016; 11(3):e0151860. PubMed ID: 26998755
[TBL] [Abstract][Full Text] [Related]
18. Theory of mind in users of anabolic androgenic steroids.
Vaskinn A; Hauger LE; Bjørnebekk A
Psychopharmacology (Berl); 2020 Oct; 237(10):3191-3199. PubMed ID: 32623552
[TBL] [Abstract][Full Text] [Related]
19. Public health impact of androgens.
Kanayama G; Kaufman MJ; Pope HG
Curr Opin Endocrinol Diabetes Obes; 2018 Jun; 25(3):218-223. PubMed ID: 29369918
[TBL] [Abstract][Full Text] [Related]
20. [Recent aspects of therapy with androgenic and anabolic steroids].
Schambach H; Nitschke U; Kröhne HJ
Z Gesamte Inn Med; 1983 Nov; 38(22):242-6. PubMed ID: 6666179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
